Correlation Between Nascent Biotech and Processa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Nascent Biotech and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nascent Biotech and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nascent Biotech and Processa Pharmaceuticals, you can compare the effects of market volatilities on Nascent Biotech and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nascent Biotech with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nascent Biotech and Processa Pharmaceuticals.
Diversification Opportunities for Nascent Biotech and Processa Pharmaceuticals
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Nascent and Processa is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Nascent Biotech and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and Nascent Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nascent Biotech are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of Nascent Biotech i.e., Nascent Biotech and Processa Pharmaceuticals go up and down completely randomly.
Pair Corralation between Nascent Biotech and Processa Pharmaceuticals
Given the investment horizon of 90 days Nascent Biotech is expected to generate 0.8 times more return on investment than Processa Pharmaceuticals. However, Nascent Biotech is 1.25 times less risky than Processa Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 4.80 in Nascent Biotech on August 31, 2024 and sell it today you would earn a total of 1.38 from holding Nascent Biotech or generate 28.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nascent Biotech vs. Processa Pharmaceuticals
Performance |
| Timeline |
| Nascent Biotech |
| Processa Pharmaceuticals |
Nascent Biotech and Processa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nascent Biotech and Processa Pharmaceuticals
The main advantage of trading using opposite Nascent Biotech and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nascent Biotech position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.| Nascent Biotech vs. Protokinetix | Nascent Biotech vs. Silo Pharma | Nascent Biotech vs. Vg Life Sciences | Nascent Biotech vs. Mymetics Corp |
| Processa Pharmaceuticals vs. Alpha Cognition | Processa Pharmaceuticals vs. Acurx Pharmaceuticals LLC | Processa Pharmaceuticals vs. Fennec Pharmaceuticals | Processa Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |